Trials / Completed
CompletedNCT05727137
Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
Analgesic Efficacy of Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the analgesic efficacy of daily single-shot adductor canal block(ABC) versus continuous ACB after total knee arthroplasty (TKA).
Detailed description
Patients 19-75 years old, of ASA classification I-III scheduled for unilateral TKA, will be enrolled and randomized into two groups, single-shot ACB group and continuous ACB group. In both groups, participants will be administered a single-shot ACB immediately after the end of the operation. The single-shot ACB group will receive two separate single-shot ACBs, on the first and second postoperative day. A nerve block catheter will be placed in patients in the continuous ACB group, which will be connected to a patient-controlled analgesia pump until the second postoperative day. The primary outcome of this study is the average NRS pain score at rest from the end of surgery to 2 days after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Single shot adductor canal block | Single shot adductor canal block on the the first and second postoperative day. |
| PROCEDURE | Continuous adductor canal block | A catheter will be placed in the adductor canal and connected to a continuous patient-controlled analgesia pump. |
Timeline
- Start date
- 2023-02-21
- Primary completion
- 2023-10-27
- Completion
- 2024-03-08
- First posted
- 2023-02-14
- Last updated
- 2024-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05727137. Inclusion in this directory is not an endorsement.